JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF Hedged (0P0001INX1)
Market Closed
15 Oct, 03:20 PM
SIX SIX Primary 113. 65
CHF +2.18
+1.9557%
- Market Cap
- Div Yield
0 Volume
111.47 CHF
Previous Close Want to track 0P0001INX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0P0001INX1 closed yesterday higher at 113.65 CHF, an increase of 1.9557% from Wednesday's close, completing a monthly decrease of -2.4547% or -2.86 CHF. Over the past 12 months, 0P0001INX1 stock gained 15.9576%.
0P0001INX1 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
0P0001INX1 Chart
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF Hedged (0P0001INX1) FAQ
What is the stock price today?
The current price is 113.65 CHF.
On which exchange is it traded?
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF Hedged is listed on SIX.
What is its stock symbol?
The ticker symbol is 0P0001INX1.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF Hedged ever had a stock split?
No, there has never been a stock split.
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF Hedged Profile
| SIX Exchange | US Country |
Contact Information
Address: -
Phone: -
2026 © Marketlog. All Rights Reserved.
